Literature DB >> 8655678

Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens.

R A Burnett1, S R Howatson, S Lang, F D Lee, A M Lessells, K M McLaren, E R Nairn, S Ogston, A J Robertson, J G Simpson, G D Smith, H B Tavadia, F Walker.   

Abstract

AIMS: To evaluate the ability of histopathologists to sub-classify non-small cell lung carcinomas on bronchial biopsy material using the current World Health Organisation (WHO) classification.
METHODS: Twelve histopathologists each reviewed 100 randomly selected bronchial biopsy specimens which had originally been reported as showing non-small cell lung carcinoma. For each case, two sections were circulated, one stained by haematoxylin and eosin and the other by a standard method for mucin (alcian blue/periodic acid Schiff). The participants were allowed to indicate their degree of confidence in their classification of each case. A standard proforma was completed and the results were analysed using kappa statistics.
RESULTS: Where the participants were confident in their classification, they were actually quite good at sub-classifying the non-small cell carcinoma sections (kappa = 0.71, standard error = 0.058). Overall, however, the results were only fair (kappa = 0.39, standard error = 0.034).
CONCLUSIONS: The majority of non-small cell lung carcinomas can be correctly categorised on adequate bronchial biopsy material. Where a confident diagnosis was made, both squamous carcinoma (kappa = 0.73) and adenocarcinoma (kappa = 0.83) were well recognised.

Entities:  

Mesh:

Year:  1996        PMID: 8655678      PMCID: PMC500345          DOI: 10.1136/jcp.49.2.130

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Observer variability in histopathological reporting of cervical biopsy specimens.

Authors:  A J Robertson; J M Anderson; J S Beck; R A Burnett; S R Howatson; F D Lee; A M Lessells; K M McLaren; S M Moss; J G Simpson
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

2.  Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders.

Authors:  A J Robertson; J S Beck; R A Burnett; S R Howatson; F D Lee; A M Lessells; K M McLaren; S M Moss; J G Simpson; G D Smith
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

3.  Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas.

Authors:  M T Chuang; A Marchevsky; A S Teirstein; P A Kirschner; J Kleinerman
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

4.  Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

Authors:  V L Roggli; R T Vollmer; S D Greenberg; M H McGavran; H J Spjut; R Yesner
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

5.  How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party.

Authors:  J S Thomas; D Lamb; T Ashcroft; B Corrin; C W Edwards; A R Gibbs; W E Kenyon; R J Stephens; W F Whimster
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

6.  Observer variability in histopathological reporting of malignant bronchial biopsy specimens.

Authors:  R A Burnett; J Swanson Beck; S R Howatson; F D Lee; A M Lessells; K M McLaren; S Ogston; A J Robertson; J G Simpson; G D Smith
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

  6 in total
  6 in total

1.  Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category.

Authors:  S L Edwards; C Roberts; M E McKean; J S Cockburn; R R Jeffrey; K M Kerr
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

2.  Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Authors:  Erik Thunnissen; Evan Boers; Daniëlle A M Heideman; Katrien Grünberg; Dirk J Kuik; Arnold Noorduin; Matthijs van Oosterhout; Divera Pronk; Cees Seldenrijk; Hannie Sietsma; Egbert F Smit; Robertjan van Suylen; Jan von der Thusen; Bart Vrugt; Anne Wiersma; Birgit I Witte; Michael den Bakker
Journal:  Virchows Arch       Date:  2012-10-12       Impact factor: 4.064

3.  Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.

Authors:  Matthew D Wilkerson; Jason M Schallheim; D Neil Hayes; Patrick J Roberts; Roy R L Bastien; Michael Mullins; Xiaoying Yin; C Ryan Miller; Leigh B Thorne; Katherine B Geiersbach; Kenneth L Muldrew; William K Funkhouser; Cheng Fan; Michele C Hayward; Steven Bayer; Charles M Perou; Philip S Bernard
Journal:  J Mol Diagn       Date:  2013-05-20       Impact factor: 5.568

4.  Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Authors:  Juneko E Grilley-Olson; D Neil Hayes; Dominic T Moore; Kevin O Leslie; Matthew D Wilkerson; Bahjat F Qaqish; Michele C Hayward; Christopher R Cabanski; Xiaoying Yin; Mark A Socinski; Thomas E Stinchcombe; Leigh B Thorne; Timothy Craig Allen; Peter M Banks; Mary B Beasley; Alain C Borczuk; Philip T Cagle; Rebecca Christensen; Thomas V Colby; Georgean G Deblois; Göran Elmberger; Paolo Graziano; Craig F Hart; Kirk D Jones; Diane M Maia; C Ryan Miller; Keith V Nance; William D Travis; William K Funkhouser
Journal:  Arch Pathol Lab Med       Date:  2012-05-14       Impact factor: 5.534

Review 5.  Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System.

Authors:  David E Dawe; Peter M Ellis
Journal:  J Pers Med       Date:  2012-09-10

6.  A deep learning model for the classification of indeterminate lung carcinoma in biopsy whole slide images.

Authors:  Fahdi Kanavati; Gouji Toyokawa; Seiya Momosaki; Hiroaki Takeoka; Masaki Okamoto; Koji Yamazaki; Sadanori Takeo; Osamu Iizuka; Masayuki Tsuneki
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.